Cargando…

Cost-Effectiveness of Extending the National Influenza Vaccination Program in South Korea: Does Vaccination of Older Adults Provide Health Benefits to the Entire Population?

The South Korean government has successfully improved influenza vaccination coverage for individuals aged 65 years or older as part of its National Immunization Program (NIP). Those aged 50–64 years without funded vaccination care have significantly lower vaccination rates and face a substantial ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Gyeongseon, Kang, Daewon, Cheong, Hee Jin, Choi, Sang-Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228362/ https://www.ncbi.nlm.nih.gov/pubmed/35746540 http://dx.doi.org/10.3390/vaccines10060932

Ejemplares similares

Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea
por: Yun, Jae-Won, et al.
Publicado: (2019)

Influenza vaccine coverage rates and perceptions on vaccination in South Korea
por: Kee, Sae Yoon, et al.
Publicado: (2007)

The "influenza vaccine" – benefit, risk, costs
por: Allwinn, R., et al.
Publicado: (2002)

Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years
por: Choi, Min Joo, et al.
Publicado: (2022)

Contracting Out National Immunization Program Does Not Improve Vaccination Rate Nor Socioeconomic Inequality: A Case Study of Seasonal Influenza Vaccination in South Korea
por: Moon, Daseul, et al.
Publicado: (2021)

Costs of seasonal influenza vaccination in South Africa
por: Fraser, Heather, et al.
Publicado: (2022)

The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019
por: Seo, Jeongmin, et al.
Publicado: (2022)

Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children
por: Prosser, Lisa A., et al.
Publicado: (2006)

Planning influenza vaccination programs: a cost benefit model
por: Duncan, Ian G, et al.
Publicado: (2012)

Costs and benefits of influenza vaccination: more evidence, same challenges
por: Ciancio, Bruno Christian, et al.
Publicado: (2014)

A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea
por: Choi, Min Joo, et al.
Publicado: (2022)

The Cost of Cost-Sharing: The Impact of Medicaid Benefit Design on Influenza Vaccination Uptake
por: Stoecker, Charles, et al.
Publicado: (2017)

Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea
por: Kim, Yun-Kyung, et al.
Publicado: (2018)

Influenza and Pneumococcal Vaccine Coverage Rates among Patients Admitted to a Teaching Hospital in South Korea
por: Yang, Tae Un, et al.
Publicado: (2015)

Impact of national Covid-19 vaccination Campaign, South Korea
por: Yi, Seonju, et al.
Publicado: (2022)

Cost-benefit analysis of influenza vaccination in a public healthcare unit
por: Colombo, Giorgio L, et al.
Publicado: (2006)

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines
por: Trombetta, Claudia Maria, et al.
Publicado: (2022)

Workplace influenza vaccination in private hospital setting: a cost-benefit analysis
por: Tohiar, Mohd. Ab. Hadi, et al.
Publicado: (2022)

Concurrent Tuberculosis and Influenza, South Korea
por: Noh, Ji Yun, et al.
Publicado: (2013)

Cost-Benefit Analysis of Haemophilus Influenzae Type B Immunization in Korea
por: Shin, Sangjin, et al.
Publicado: (2008)

The impact of the COVID-19 pandemic and the expansion of free vaccination policy on influenza vaccination coverage: An analysis of vaccination behavior in South Korea
por: Yeo, Muhan, et al.
Publicado: (2023)

Physician Attitudes toward the Herpes Zoster Vaccination in South Korea
por: Yang, Tae Un, et al.
Publicado: (2014)

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
por: Kim, Hye-Young, et al.
Publicado: (2020)

Inoculation of an Entire Community with Haffkine's Plague Vaccine
por: Bennett, C. H., et al.
Publicado: (1899)

Influenza vaccination in Western Australian children: Exploring the health benefits and cost savings of increased vaccine coverage in children
por: Blyth, Christopher C., et al.
Publicado: (2023)

Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea
por: Choi, Gyeyoung, et al.
Publicado: (2022)

Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea
por: Jung, Yeon Haw, et al.
Publicado: (2022)

Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea
por: Lim, Sookyung, et al.
Publicado: (2022)

Benefit–Cost Analysis of Foot-and-Mouth Disease Vaccination at the Farm-Level in South Vietnam
por: Truong, Dinh Bao, et al.
Publicado: (2018)

Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea
por: Min, Serim, et al.
Publicado: (2023)

Vaccine-Related Errors in Reconstitution in South Korea: A National Physicians’ and Nurses’ Survey
por: Lee, Young Hwa, et al.
Publicado: (2021)

Health Benefits of Universal Influenza Vaccination Strategy
por: Viboud, Cécile, et al.
Publicado: (2008)

Influenza vaccination and dementia risk; an unanticipated benefit?
por: Ali, Eman, et al.
Publicado: (2022)

Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016–2017 season
por: Noh, Ji Yun, et al.
Publicado: (2017)

COVID-19 Vaccination in Korea
por: Park, Wan Beom, et al.
Publicado: (2023)

1168. Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

Is Hib Vaccine of Economic Value in South Korea?
por: Griffiths, Ulla K., et al.
Publicado: (2009)

Factors associated with influenza vaccination coverage among the elderly in South Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV)
por: Kwon, David Soonil, et al.
Publicado: (2016)

The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia
por: de Boer, Pieter T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f3qngvi7euvbkn16sge1vubrqt